Drugs / GO306
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07128914 | Jul 2025 → Dec 2026 expected | — | GeneSail Biotech (Shanghai) Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GO306 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07128914 ↗ |
| Route | Other | “Intratumoral or intracavitary injection of GO306” NCT07128914 ↗ |